by Neoteryx, on December 1,2021
December 2021 — US-based medical device company Neoteryx announces its user-friendly at-home specimen collection kit for children in support of labs and research customers that conduct pediatric studies, clinical trials …
Read Storyby Neoteryx, on January 21,2019
With significant worldwide growth in demand for microsampling technology, Neoteryx is opening new offices! We're expanding our European operations to better meet the needs of both new and existing customers …
Read Storyby Neoteryx, on November 12,2018
At-home blood sampling streamlines the process of therapeutic drug monitoring and creates comfort and emotional safety for children UNITED KINGDOM and TORRANCE, CA (November 07, 2018) – Neoteryx LLC, inventor of Volumetric …
Read StoryThe latest product releases, company news and microsampling industry updates from Neoteryx.
If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com
Fact Sheet & FAQs
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.